These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 11251310)

  • 1. Prevention of hepatitis C virus infection in a chimpanzee by vaccination and epitope mapping of antiserum directed against hypervariable region 1.
    Goto J; Nishimura S; Esumi M; Makizumi K; Rikihisa T; Nishihara T; Mizuno K; Zhou Y; Shikata T; Fujiyama S; Tomita K
    Hepatol Res; 2001 Mar; 19(3):270-283. PubMed ID: 11251310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental vaccine activities of recombinant E1 and E2 glycoproteins and hypervariable region 1 peptides of hepatitis C virus in chimpanzees.
    Esumi M; Rikihisa T; Nishimura S; Goto J; Mizuno K; Zhou YH; Shikata T
    Arch Virol; 1999; 144(5):973-80. PubMed ID: 10416378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the E2 Hypervariable Region (HVR1) in the Immunogenicity of a Recombinant Hepatitis C Virus Vaccine.
    Law JLM; Logan M; Wong J; Kundu J; Hockman D; Landi A; Chen C; Crawford K; Wininger M; Johnson J; Mesa Prince C; Dudek E; Mehta N; Tyrrell DL; Houghton M
    J Virol; 2018 Jun; 92(11):. PubMed ID: 29540595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple sequence-reactive antibodies induced by a single peptide immunization with hypervariable region 1 of hepatitis C virus.
    Zhou YH; Moriyama M; Esumi M
    Virology; 1999 Apr; 256(2):360-70. PubMed ID: 10191201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Murine antibodies against E2 and hypervariable region 1 cross-reactively capture hepatitis C virus.
    Esumi M; Ahmed M; Zhou YH; Takahashi H; Shikata T
    Virology; 1998 Nov; 251(1):158-64. PubMed ID: 9813211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypervariable region 1 shielding of hepatitis C virus is a main contributor to genotypic differences in neutralization sensitivity.
    Prentoe J; Velázquez-Moctezuma R; Foung SK; Law M; Bukh J
    Hepatology; 2016 Dec; 64(6):1881-1892. PubMed ID: 27351277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Recombinant Hepatitis C Virus Genotype 1a E1/E2 Envelope Glycoprotein Vaccine Elicits Antibodies That Differentially Neutralize Closely Related 2a Strains through Interactions of the N-Terminal Hypervariable Region 1 of E2 with Scavenger Receptor B1.
    Johnson J; Freedman H; Logan M; Wong JAJ; Hockman D; Chen C; He J; Beard MR; Eyre NS; Baumert TF; Tyrrell DL; Law JLM; Houghton M
    J Virol; 2019 Nov; 93(22):. PubMed ID: 31462563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequences in the hypervariable region 1 of hepatitis C virus show only minimal variability in the presence of antibodies against hypervariable region 1 during acute infection in chimpanzees.
    Zhou YH; Sugitani M; Esumi M
    Arch Virol; 2002 Oct; 147(10):1955-62. PubMed ID: 12376756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mimotopes of the hepatitis C virus hypervariable region 1, but not the natural sequences, induce cross-reactive antibody response by genetic immunization.
    Zucchelli S; Roccasecca R; Meola A; Ercole BB; Tafi R; Dubuisson J; Galfré G; Cortese R; Nicosia A
    Hepatology; 2001 Mar; 33(3):692-703. PubMed ID: 11230750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Broadly cross-reactive, high-affinity antibody to hypervariable region 1 of the hepatitis C virus in rabbits.
    Shang D; Zhai W; Allain JP
    Virology; 1999 Jun; 258(2):396-405. PubMed ID: 10366577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequence evolution of the hypervariable region in the putative envelope region E2/NS1 of hepatitis C virus is correlated with specific humoral immune responses.
    van Doorn LJ; Capriles I; Maertens G; DeLeys R; Murray K; Kos T; Schellekens H; Quint W
    J Virol; 1995 Feb; 69(2):773-8. PubMed ID: 7815542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal antibodies with broad specificity for hepatitis C virus hypervariable region 1 variants can recognize viral particles.
    Cerino A; Meola A; Segagni L; Furione M; Marciano S; Triyatni M; Liang TJ; Nicosia A; Mondelli MU
    J Immunol; 2001 Oct; 167(7):3878-86. PubMed ID: 11564805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccination of chimpanzees with plasmid DNA encoding the hepatitis C virus (HCV) envelope E2 protein modified the infection after challenge with homologous monoclonal HCV.
    Forns X; Payette PJ; Ma X; Satterfield W; Eder G; Mushahwar IK; Govindarajan S; Davis HL; Emerson SU; Purcell RH; Bukh J
    Hepatology; 2000 Sep; 32(3):618-25. PubMed ID: 10960458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypervariable Region 1 in Envelope Protein 2 of Hepatitis C Virus: A Linchpin in Neutralizing Antibody Evasion and Viral Entry.
    Prentoe J; Bukh J
    Front Immunol; 2018; 9():2146. PubMed ID: 30319614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo and in vitro evidence that cross-reactive antibodies to C-terminus of hypervariable region 1 do not neutralize heterologous hepatitis C virus.
    Esumi M; Zhou YH; Tanoue T; Tomoguri T; Hayasaka I
    Vaccine; 2002 Aug; 20(25-26):3095-103. PubMed ID: 12163260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ontogeny of hepatitis C virus (HCV) hypervariable region 1 (HVR1) heterogeneity and HVR1 antibody responses over a 3 year period in a patient infected with HCV type 2b.
    Majid A; Jackson P; Lawal Z; Pearson GM; Parker H; Alexander GJ; Allain JP; Petrik J
    J Gen Virol; 1999 Feb; 80 ( Pt 2)():317-325. PubMed ID: 10073690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal Antibodies Directed toward the Hepatitis C Virus Glycoprotein E2 Detect Antigenic Differences Modulated by the N-Terminal Hypervariable Region 1 (HVR1), HVR2, and Intergenotypic Variable Region.
    Alhammad Y; Gu J; Boo I; Harrison D; McCaffrey K; Vietheer PT; Edwards S; Quinn C; Coulibaly F; Poumbourios P; Drummer HE
    J Virol; 2015 Dec; 89(24):12245-61. PubMed ID: 26378182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HCV selection and HVR1 evolution in a chimpanzee chronically infected with HCV-1 over 12 years.
    Lu L; Tatsunori N; Li C; Waheed S; Gao F; Robertson BH
    Hepatol Res; 2008 Jul; 38(7):704-16. PubMed ID: 18328069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody responses to hepatitis C virus hypervariable region 1: evidence for cross-reactivity and immune-mediated sequence variation.
    Mondelli MU; Cerino A; Lisa A; Brambilla S; Segagni L; Cividini A; Bissolati M; Missale G; Bellati G; Meola A; Bruniercole B; Nicosia A; Galfrè G; Silini E
    Hepatology; 1999 Aug; 30(2):537-45. PubMed ID: 10421665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Occurrence of antibodies reactive with more than one variant of the putative envelope glycoprotein (gp70) hypervariable region 1 in viremic hepatitis C virus-infected patients.
    Scarselli E; Cerino A; Esposito G; Silini E; Mondelli MU; Traboni C
    J Virol; 1995 Jul; 69(7):4407-12. PubMed ID: 7539508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.